Stock Research: TransMedics Group

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

TransMedics Group

NasdaqGM:TMDX US89377M1099
36
  • Value
    21
  • Growth
    83
  • Safety
    Safety
    14
  • Combined
    17
  • Sentiment
    67
  • 360° View
    360° View
    36
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

TransMedics Group, Inc. is a medical technology company transforming organ transplant therapy. It specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation using its Organ Care System (OCS) and offers a National OCS Program (NOP) providing outsourced organ procurement and transplant logistics services in the United States. In the last fiscal year, the company had a market cap of $3971 million, profits of $262 million, revenue of $442 million, and 728 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 36 (better than 36% compared with alternatives), overall professional sentiment and financial characteristics for the stock TransMedics Group are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for TransMedics Group. The consolidated Growth Rank has a good rank of 83, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 83% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 67, which means that professional investors are more optimistic about the stock than for 67% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 14, which means that the share price of TransMedics Group is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 86% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 21, which means that the company has a financing structure that is riskier than those of 79% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
14 15 19 47
Growth
83 99 71 75
Safety
Safety
21 34 65 68
Sentiment
67 54 58 49
360° View
360° View
36 62 76 84
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
74 64 72 56
Opinions Change
43 50 50 50
Pro Holdings
n/a 33 19 24
Market Pulse
60 67 75 66
Sentiment
67 54 58 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
14 15 19 47
Growth
83 99 71 75
Safety Safety
21 34 65 68
Combined
17 51 65 84
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
24 29 21 12
Price vs. Earnings (P/E)
25 31 14 41
Price vs. Book (P/B)
17 19 17 56
Dividend Yield
1 1 1 1
Value
14 15 19 47
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
92 89 96 97
Profit Growth
98 98 61 17
Capital Growth
1 98 6 93
Stock Returns
89 45 85 47
Growth
83 99 71 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
10 7 54 45
Refinancing
39 58 45 65
Liquidity
56 61 50 43
Safety Safety
21 34 65 68

Similar Stocks

Discover high‑ranked alternatives to TransMedics Group and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Cigna

NYSE:CI
Country: USA
Industry: Health Care Services
Size: XX-Large
Full Stock Analysis

TEGNA

NYSE:TGNA
Country: USA
Industry: Broadcasting
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.